Amphastar Pharma (AMPH) Misses Q2 EPS by 4c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Amphastar Pharma (AMPH) Misses Q2 EPS by 4c

Amphastar Pharmaceuticals (AMPH) PT Lowered to $22 at Needham & Company

August 9, 2018 1:38 PM EDT

Needham & Company lowered its price target on Amphastar Pharmaceuticals (NASDAQ: AMPH) to $22.00 (from $24.00) while maintaining a Buy rating.

Analyst Serge Belanger remains positive as the recent approval of generic Isuprel, along with medroxyprogesterone and neostigmine will continue driving growth in... More

Amphastar Pharmaceuticals (AMPH) PT Lowered to $24 at Piper Jaffray

August 9, 2018 4:37 AM EDT

Piper Jaffray lowered its price target on Amphastar Pharmaceuticals (NASDAQ: AMPH) to $24.00 (from $26.00) while maintaining a Overweight rating.

... More